Version: 1.0
Alzheimer’s disease affects more than 46 million people worldwide.
Despite significant global investment, there have been no new drugs for 20 years.
There is now compelling evidence that Alzheimer’s disease takes hold in the brain decades before dementia symptoms appear, providing a window of opportunity for preventative intervention.
The European Prevention of Alzheimer’s Dementia (EPAD) initiative is a unique and ground-breaking approach to streamlining the testing and development of preventative treatments for Alzheimer’s disease.